These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
84 related articles for article (PubMed ID: 8042825)
21. Effect of rosuvastatin therapy on coronary artery stenoses assessed by quantitative coronary angiography: a study to evaluate the effect of rosuvastatin on intravascular ultrasound-derived coronary atheroma burden. Ballantyne CM; Raichlen JS; Nicholls SJ; Erbel R; Tardif JC; Brener SJ; Cain VA; Nissen SE; Circulation; 2008 May; 117(19):2458-66. PubMed ID: 18378607 [TBL] [Abstract][Full Text] [Related]
22. Paradoxical increase in lumen size during progression of coronary atherosclerosis: observations from the REVERSAL trial. Sipahi I; Tuzcu EM; Schoenhagen P; Nicholls SJ; Chen MS; Crowe T; Loyd AB; Kapadia S; Nissen SE Atherosclerosis; 2006 Nov; 189(1):229-35. PubMed ID: 16427643 [TBL] [Abstract][Full Text] [Related]
23. Advantages and limitations of serial coronary arteriography for the assessment of progression and regression of coronary atherosclerosis. Implications for clinical trials. Waters D; Lespérance J; Craven TE; Hudon G; Gillam LD Circulation; 1993 Mar; 87(3 Suppl):II38-47. PubMed ID: 8443922 [TBL] [Abstract][Full Text] [Related]
24. Preventing angiographic progression of coronary atherosclerosis with pravastatin. Daida H; Ouchi Y; Saito Y; Yamada N; Nishide T; Mokuno H; Kurata T; Sato H; Eto M; Ako JY; Tango T; Yamaguchi H; J Atheroscler Thromb; 2003; 10(1):25-31. PubMed ID: 12621161 [TBL] [Abstract][Full Text] [Related]
25. The effect of dietary omega-3 fatty acids on coronary atherosclerosis. A randomized, double-blind, placebo-controlled trial. von Schacky C; Angerer P; Kothny W; Theisen K; Mudra H Ann Intern Med; 1999 Apr; 130(7):554-62. PubMed ID: 10189324 [TBL] [Abstract][Full Text] [Related]
26. Do the extent and direction of arterial remodelling predict subsequent progression of coronary atherosclerosis? A serial intravascular ultrasound study. Sipahi I; Tuzcu EM; Moon KW; Nicholls SJ; Schoenhagen P; Zhitnik J; Crowe TD; Kapadia S; Nissen SE Heart; 2008 May; 94(5):623-7. PubMed ID: 18070944 [TBL] [Abstract][Full Text] [Related]
27. Effect on coronary atherosclerosis of decrease in plasma cholesterol concentrations in normocholesterolaemic patients. Harvard Atherosclerosis Reversibility Project (HARP) Group. Sacks FM; Pasternak RC; Gibson CM; Rosner B; Stone PH Lancet; 1994 Oct; 344(8931):1182-6. PubMed ID: 7934538 [TBL] [Abstract][Full Text] [Related]
28. A pan-coronary artery angiographic study of the association between diabetes mellitus and progression or regression of coronary atherosclerosis. Iijima R; Ndrepepa G; Kujath V; Harada Y; Kufner S; Schunkert H; Nakamura M; Kastrati A Heart Vessels; 2017 Apr; 32(4):376-384. PubMed ID: 27557547 [TBL] [Abstract][Full Text] [Related]
29. Serial quantitative coronary angiography and coronary events. Mack WJ; Xiang M; Selzer RH; Hodis HN Am Heart J; 2000 Jun; 139(6):993-9. PubMed ID: 10827379 [TBL] [Abstract][Full Text] [Related]
30. Effects on coronary artery disease of lipid-lowering diet, or diet plus cholestyramine, in the St Thomas' Atherosclerosis Regression Study (STARS). Watts GF; Lewis B; Brunt JN; Lewis ES; Coltart DJ; Smith LD; Mann JI; Swan AV Lancet; 1992 Mar; 339(8793):563-9. PubMed ID: 1347091 [TBL] [Abstract][Full Text] [Related]
35. [Regression of coronary atherosclerosis: possible--and clinically relevant?]. Niederhauser HU Schweiz Rundsch Med Prax; 1991 Sep; 80(39):1019-23. PubMed ID: 1925225 [TBL] [Abstract][Full Text] [Related]
36. Serial coronary angiographic evidence that antioxidant vitamin intake reduces progression of coronary artery atherosclerosis. Hodis HN; Mack WJ; LaBree L; Cashin-Hemphill L; Sevanian A; Johnson R; Azen SP JAMA; 1995 Jun; 273(23):1849-54. PubMed ID: 7776501 [TBL] [Abstract][Full Text] [Related]
37. Regression of coronary atherosclerosis through healthy lifestyle in coronary artery disease patients--Mount Abu Open Heart Trial. Gupta SK; Sawhney RC; Rai L; Chavan VD; Dani S; Arora RC; Selvamurthy W; Chopra HK; Nanda NC Indian Heart J; 2011; 63(5):461-9. PubMed ID: 23550427 [TBL] [Abstract][Full Text] [Related]
38. The role of a common variant of the cholesteryl ester transfer protein gene in the progression of coronary atherosclerosis. The Regression Growth Evaluation Statin Study Group. Kuivenhoven JA; Jukema JW; Zwinderman AH; de Knijff P; McPherson R; Bruschke AV; Lie KI; Kastelein JJ N Engl J Med; 1998 Jan; 338(2):86-93. PubMed ID: 9420339 [TBL] [Abstract][Full Text] [Related]
39. Coronary artery disease regression. Convincing evidence for the benefit of aggressive lipoprotein management. Superko HR; Krauss RM Circulation; 1994 Aug; 90(2):1056-69. PubMed ID: 8044919 [TBL] [Abstract][Full Text] [Related]
40. The influence of angiographic endpoints on the outcome of lipid intervention studies. A proposal for standardization. REGRESS study group. Jukema JW; van Boven AJ; Zinderman AH; Bal ET; Reiber JH; Bruschke AV Angiology; 1996 Jul; 47(7):633-42. PubMed ID: 8686956 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]